Friends of Cancer Research Annual Meeting 2020 Day 2

 

Image
Friends of Cancer Research Annual Meeting

Friends of Cancer Research Annual Meeting 2020: Day 2
Optimizing the Use of Accelerated Approval
Virtual Meeting
November 19, 2020
12:00PM EST - 1:15PM EST

Register Today

Friends of Cancer Research(Friends) is proud to host our 13thAnnual Meeting to address critical issues in the development of new oncology drugs. Each meeting brings together leaders from federal health and regulatory agencies, academic research, the private sector, and patient advocates to propose unique approaches toward current challenges in drug development.

We are excited to be hosting our 8th Virtual Meeting in 2020. Please register above and check below for the current draft agenda.

For more details for Day 1 of the Annual Meeting, click here.

Draft Agenda

12:00 PM Welcoming Remarks 

  • Jeff Allen, Friends of Cancer Research 

12:05 PM Fireside Chat 

  • Patrizia Cavazzoni, Acting Director, Center for Drug Evaluation and Research, FDA 
  • Peter Marks, Director, Center for Biologics Evaluation and Research, FDA 
  • Moderated by Kate Rawson, Prevision Policy 

12:25 PM Session 2: Optimizing the Use of Accelerated Approval 

Objective: This session will characterize learnings from the accelerated approval program and describe regulatory and policy opportunities to optimize its use and facilitate oncology drug development. 

12:58 PM Closing Conversation

  • Richard Pazdur, FDA 
  • Jeff Allen, Friends of Cancer Research 

1:13 PM Closing remarks 

Jeff Allen, Friends of Cancer Research 

1:15 PM Adjourn